香港六合彩中特网

Published in听Cell Death and Disease, the study found that the drug brimonidine, which is routinely used to lower eye pressure in glaucoma patients, has been found to reduce the formation of amyloid proteins in the retina.听

In the past, scientists have suggested that because amyloid proteins are present in the retinas of people with Alzheimer鈥檚,听the retina may be viewed as an extension of the brain. This would听provide doctors with听an opportunity to diagnose and track progression of Alzheimer鈥檚.

The IoO's researchers have now found that brimonidine reduces neurodegeneration of retina cells by cutting the levels of beta amyloid in the eye; the drug stimulates the production of an alternative non-toxic protein that does not kill nerve cells. The researchers hope that the drug will be found to have a similar effect on the brain in further study.

Professor Francesca Cordeiro, who led the study, said: 鈥淭he findings of our study could not have come at a more significant and important moment, given the increased prevalence of Alzheimer鈥檚 disease.听 As we live longer, there will be increasing demand for therapies that can help challenge this extremely damaging disease and we believe that our findings can make a major contribution.鈥�

香港六合彩中特网 Business, 香港六合彩中特网鈥檚 technology commercialisation company, holds patents and is developing a clinical grade marker to evaluate the efficiency of neuroprotectants such as brimonidine in humans.

听

Related